Current Medicinal Chemistry


Atta-ur-Rahman, FRS
(32052 citations)
Kings College
University of Cambridge

Nobel Laureates on Editorial Board

Prof. John Gurdon

Prof. Jean-Marie Lehn

Prof. Ferid Murad

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 18 Issue: 24, August

Editorial [Hot Topic: Hot Topics in Cellular Cardiac Electrophysiology with Potential Impact on Future Drug Design (Guest Editors: Peter P. Nanasi and Valeria Kecskemeti)]

Volume:18   Issue: 24
Pp: 3595-3596
Peter P. Nanasi and Valeria Kecskemeti
DOI: 10.2174/092986711796642454
Published on: 01 March, 2012

Mechanism of Reverse Rate-Dependent Action of Cardioactive Agents

Volume:18   Issue: 24
Pp: 3597-3606
T. Banyasz, L. Barandi, G. Harmati, L. Virag, N. Szentandrassy, I. Marton, A. Zaza, A. Varro and P. P. Nanasi
DOI: 10.2174/092986711796642355
Published on: 01 March, 2012

Enhanced Repolarization Capacity: New Potential Antiarrhythmic Strategy Based on hERG Channel Activation

Volume:18   Issue: 24
Pp: 3607-3621
G. Szabo, V. Farkas, M. Grunnet, A. Mohacsi and P. P. Nanasi
DOI: 10.2174/092986711796642382
Published on: 01 March, 2012

Role of Ca2+-Sensitive K+ Currents in Controlling Ventricular Repolarization: Possible Implications for Future Antiarrhytmic Drug Therapy

Volume:18   Issue: 24
Pp: 3622-3639
N. Nagy, Z. Marton, L. Kiss, A. Varro, P. P. Nanasi and A. Toth
DOI: 10.2174/092986711796642463
Published on: 01 March, 2012

Sarcolemmal KATP Channel Modulators and Cardiac Arrhythmias

Volume:18   Issue: 24
Pp: 3640-3661
I. Baczko, Z. Husti, V. Lang, I. Lepran and P. E. Light
DOI: 10.2174/092986711796642472
Published on: 01 March, 2012

Selective Pharmacological Inhibition of the Pacemaker Channel Isoforms (HCN1-4) as New Possible Therapeutical Targets

Volume:18   Issue: 24
Pp: 3662-3674
I. Koncz, T. Szel, K. Jaeger, I. Baczko, E. Cerbai, M. N. Romanelli, J. Gy. Papp and A. Varro
DOI: 10.2174/092986711796642427
Published on: 01 March, 2012

Atrial Remodeling and Novel Pharmacological Strategies for Antiarrhythmic Therapy in Atrial Fibrillation

Volume:18   Issue: 24
Pp: 3675-3694
N. Jost, Z. Kohajda, A. A. Kristof, Z. Husti, V. Juhasz, L. Kiss, A. Varro, L. Virag and I. Baczko
DOI: 10.2174/092986711796642373
Published on: 01 March, 2012

Xanthine Derivatives in the Heart: Blessed or Cursed?

Volume:18   Issue: 24
Pp: 3695-3706
A. J. Szentmiklosi, A. Cseppento, R. Gesztelyi, J. Zsuga, A. Kortvely, G. Harmati and P. P. Nanasi
DOI: 10.2174/092986711796642391
Published on: 01 March, 2012

Cardiac Calmodulin Kinase: A Potential Target for Drug Design

Volume:18   Issue: 24
Pp: 3707-3713
T. Banyasz, N. Szentandrassy, A. Toth, P. P. Nanasi, J. Magyar and Y. Chen-Izu
DOI: 10.2174/092986711796642409
Published on: 01 March, 2012

Long Term Regulation of Cardiac L-Type Calcium Channel by Small G Proteins

Volume:18   Issue: 24
Pp: 3714-3719
J. Magyar, A. Jenes, K. Kistamas, F. Ruzsnavszky, P. P. Nanasi, J. Satin, N. Szentandrassy and T. Banyasz
DOI: 10.2174/092986711796642436
Published on: 01 March, 2012

Can the Electrophysiological Action of Rosiglitazone Explain its Cardiac Side Effects?

Volume:18   Issue: 24
Pp: 3720-3728
A. Szebeni, N. Szentandrassy, P. Pacher, J. Simko, P. P. Nanasi and V. Kecskemeti
DOI: 10.2174/092986711796642364
Published on: 01 March, 2012

Modified cAMP Derivatives: Powerful Tools in Heart Research

Volume:18   Issue: 24
Pp: 3729-3736
N. Szentandrassy, G. Harmati, V. Farkas, B. Horvath, B. Hegyi, J. Magyar, G. Szenasi, I. Marton and P. P. Nanasi
DOI: 10.2174/092986711796642445
Published on: 01 March, 2012

Powerful Technique to Test Selectivity of Agents Acting on Cardiac Ion Channels: The Action Potential Voltage-Clamp

Volume:18   Issue: 24
Pp: 3737-3756
N. Szentandrassy, D. Nagy, F. Ruzsnavszky, G. Harmati, T. Banyasz, J. Magyar, A. J. Szentmiklosi and P. P. Nanasi
DOI: 10.2174/092986711796642418
Published on: 01 March, 2012